FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to ophthalmology, and represents elastomer material for ophthalmic agent delivery into individual's eye and methods of using said material. Elastomer material provides overlapping of venous blood flow in episcleral eye vein in subject. Through this vein introduction of ophthalmic agent can be performed. Ophthalmic agent, introduced so, after removal of elastomer material gets into ciliary canal and trabecular network.
EFFECT: described manipulations provide prolonged action of preparation on eye structures, creating of reparation depot.
14 cl, 10 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW THERAPEUTIC APPROACH TO INTRAOCULAR PRESSURE INCREASE | 2007 |
|
RU2458703C2 |
| REDUCTION OF INTRAOCULAR PRESSURE BY INTRACHAMBER BIMATOPROST IMPLANTS | 2011 |
|
RU2586298C2 |
| INTRACHAMBER IMPLANTS WITH PROLONGED RELEASE OF THERAPEUTIC AGENT | 2011 |
|
RU2565445C2 |
| INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
| METHOD OF TREATING ELEVATED INTRAOCULAR PRESSURE USING INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEM | 2014 |
|
RU2664686C2 |
| COMPOSITIONS AND METHODS FOR INSERTION OF TUBULIN-BINDING AGENTS FOR EYE DISEASE THERAPY | 2002 |
|
RU2354398C2 |
| PHARMACEUTICAL PREPARATIVE FORMS OF LATRUNCULIN | 2007 |
|
RU2434633C2 |
| PHARMACEUTICAL COMPOSITIONS AND METHODS FOR APPLICATION OF 4-PREGNEN-11β-17-21-TRIOL-3,20-DIONE DERIVATIVES | 2012 |
|
RU2683775C2 |
| SUSPENSIONS OF NANOPARTICLES, CONTAINING CARBOXYVINYL POLYMER | 2010 |
|
RU2571078C2 |
| 4-PREGENEN-11Β-17-21-TRIOL-3,20-DIONE DERIVATIVES FOR TREATING EYE DISEASES | 2012 |
|
RU2688159C2 |
